The Covid-19, Epidemiology, Clinic and Prevention.
作者信息
Antonelli Alessandro, Elia Giusy, Ferrari Silvia Martina, Foddis Rudy, De Marco Salvatore, Cristaudo Alfonso, Fallahi Poupak
机构信息
1Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 2Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; 3U.O. 5 Medicine, AOUP, Pisa, Italy.
出版信息
Curr Genomics. 2020 Apr;21(3):157. doi: 10.2174/1389202921999200427133052.
Abstract
摘要
相似文献
1
The Covid-19, Epidemiology, Clinic and Prevention.新型冠状病毒肺炎，流行病学、临床与预防
Curr Genomics. 2020 Apr;21(3):157. doi: 10.2174/1389202921999200427133052.
引用本文的文献
1
Thyroid Autoimmunity and SARS-CoV-2 Infection.甲状腺自身免疫与2019冠状病毒病感染
J Clin Med. 2023 Oct 5;12(19):6365. doi: 10.3390/jcm12196365.
2
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages.全球报告的 SARS-CoV-2 疫苗在临床前和临床阶段的更新综述。
Int Immunopharmacol. 2021 Jul;96:107763. doi: 10.1016/j.intimp.2021.107763. Epub 2021 May 6.
3
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.COVID-19 与风湿性自身免疫性系统性疾病：一项大型意大利患者系列报告。
Clin Rheumatol. 2020 Nov;39(11):3195-3204. doi: 10.1007/s10067-020-05334-7. Epub 2020 Aug 27.
本文引用的文献
1
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
2
Current Drugs with Potential for Treatment of COVID-19: A Literature Review.当前具有治疗新冠病毒病潜力的药物：文献综述
J Pharm Pharm Sci. 2020;23(1):58-64. doi: 10.18433/jpps31002.
3
Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV.对 2019 年新型冠状病毒的洞察——来自 SARS-CoV 和 MERS-CoV 的更新中期综述和经验教训。
Int J Infect Dis. 2020 May;94:119-124. doi: 10.1016/j.ijid.2020.03.071. Epub 2020 Apr 1.
4
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.对于重症新冠病毒感染患者，没有证据表明羟氯喹和阿奇霉素联合使用能实现快速的抗病毒清除或带来临床益处。
Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30.
5
The versatile heparin in COVID-19.新冠疫情中用途广泛的肝素。
J Thromb Haemost. 2020 May;18(5):1020-1022. doi: 10.1111/jth.14821. Epub 2020 Apr 27.
6
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.严重 COVID-19 中的细胞因子释放综合征：白细胞介素-6 受体拮抗剂托珠单抗可能是降低死亡率的关键。
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
7
Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.2019新型冠状病毒感染患者队列中与疾病进展相关的危险因素。
Ann Palliat Med. 2020 Mar;9(2):428-436. doi: 10.21037/apm.2020.03.26. Epub 2020 Mar 17.
8
Emerging prophylaxis strategies against COVID-19.针对新型冠状病毒肺炎的新兴预防策略。
Monaldi Arch Chest Dis. 2020 Mar 30;90(1). doi: 10.4081/monaldi.2020.1289.
9
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.新型冠状病毒肺炎患者支气管肺泡灌洗液和外周血单个核细胞的转录组学特征。
Emerg Microbes Infect. 2020 Dec;9(1):761-770. doi: 10.1080/22221751.2020.1747363.
10
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
Zotero 插件